Related Experiment Videos
Allogeneic matings and immunization have different effects on nulliparous and multiparous mice
Journal of Immunology (Baltimore, Md. : 1950)
|July 1, 1987
Summary
Immunizing CBA/J female mice during first pregnancy with non-DBA/2 leukocytes prevents fetal loss in subsequent pregnancies. However, continued immunization increases fetal wastage, without affecting offspring sex ratio.
Area of Science:
- Reproductive immunology
- Immunogenetics
- Maternal-fetal interactions
Background:
- CBA/J female mice exhibit high spontaneous fetal loss when mated with DBA/2 males.
- Immunization with C57BL leukocytes, but not DBA/2 leukocytes, reduces fetal resorption rates.
- Previous studies established the efficacy of specific leukocyte immunization in mitigating early pregnancy loss.
Purpose of the Study:
- To investigate the long-term effects of immunization on subsequent pregnancies.
- To determine if continued immunization impacts fetal resorption rates in second pregnancies.
- To assess the influence of immunization on the sex ratio of offspring.
Main Methods:
- CBA/J female mice were immunized with C57BL or DBA/2 leukocytes during their first pregnancy.
- Subsequent pregnancies were monitored for fetal resorption rates and offspring sex ratios.
- Unimmunized CBA/J females mated with DBA/2 males served as controls.
Main Results:
- Second pregnancies in unimmunized females showed low fetal resorption rates.
- Continued immunization in multigravid, multiparous mice was linked to increased late-onset fetal resorptions.
- No significant shift in sex ratio was observed between treated and untreated pregnancies.
Conclusions:
- Untreated CBA/J females can develop immunity to trophoblast antigens during first pregnancies, leading to normal reproductive outcomes in subsequent pregnancies.
- Persistent leukocyte immunization, regardless of source, may increase fetal wastage in later pregnancies.
- Chronic immunization with male leukocytes does not alter the sex ratio of viable offspring, suggesting potential applications for immunotherapy in recurrent spontaneous abortions.